18:01 , Mar 13, 2019 |  BC Innovations  |  Distillery Therapeutics

Inhibiting CARD9 for colitis and Crohn's disease

DISEASE CATEGORY: Gastrointestinal; autoimmune disease INDICATION: Colitis; Crohn's disease Patient sample and mouse studies suggest inhibiting CARD9 could help treat colitis and Crohn's disease. In water lavage samples from Crohn's disease patients, the numbers of...
08:00 , Jan 29, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Tuberculosis Caspase recruitment domain family member 9 (CARD9) A study in mice suggests that increasing CARD9 signaling may boost the...